NCT01402843 - Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

January 31, 2013

Conditions

HypertensionDyslipidemia

Interventions

DRUG

pitavastatin, valsartan, placebo

pitavastatin 4mg/day 8 week valsartan 320mg/day 8 week

Trial Locations (10)

Chungbuk National University Hospital, Chungju

Konyang University Hospital, Daejeon

Asan Medical Center, Seoul

Gangnam Severance Hospital, Seoul

Hallym University Medical Center, Seoul

Korea University Guro Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Severance Hospital, Seoul

Ajou University Medical Center, Suwon